The state of Alabama currently has 13 active clinical trials seeking participants for Ulcerative Colitis research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/01/2023
Locations: Digestive Health Specialists, Dothan, Alabama
Conditions: Ulcerative Colitis